ClinicalTrialsFinder

Blasts 10-19 Percent of Bone Marrow Nucleated Cells Clinical Trials in Houston, Texas

1 recruitingHouston, Texas

Showing 1–1 of 1 trials

Recruiting
Phase 1

CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

Recurrent Chronic Myelomonocytic LeukemiaRefractory Chronic Myelomonocytic LeukemiaRecurrent High Risk Myelodysplastic Syndrome+4 more
M.D. Anderson Cancer Center38 enrolled1 locationNCT03896269